Position in ZTS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$952,428
-$482,637 QoQ
Shares Held
13,254
+9.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#152
of 466 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $14,160,724 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
9,856 | $5,340,273 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,744 | $3,159,110 | |
| 3 | VTRS |
Viatris Inc
|
74,483 | $1,182,785 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
13,254 | $952,428 | |
| 5 | HLN |
Haleon plc
|
101,892 | $950,650 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
35,173 | $563,820 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
4,251 | $471,603 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
5,474 | $350,060 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $952,428 | 13,254 | Shares | Other | 2026-07-20 | |
| 2026-03-31 | $1,435,065 | 12,140 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $1,337,714 | 10,632 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $2,497,825 | 17,071 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $3,059,115 | 19,616 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,005,107 | 12,178 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,222,300 | 7,502 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,227,572 | 6,283 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,615,715 | 9,320 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,494,293 | 8,831 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $691,979 | 3,506 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,271,619 | 7,309 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,215,630 | 7,059 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $669,421 | 4,022 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $963,859 | 6,577 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $695,331 | 4,689 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,532,399 | 8,915 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $441,677 | 2,342 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $296,496 | 1,215 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $226,561 | 1,167 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $217,482 | 1,167 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||